Pharma
French companion app company Voluntis has partnered with AstraZeneca to develop an app for women undergoing treatment for ovarian cancer.
GSK's Ellipta inhaler
GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients.
CVS Health has announced the launch of five new digital offerings that help customers refill prescriptions and manage their medications.
San Francisco-based TinyRx, a prescription delivery service, launched this week with $5 million in funding from Eight Partners, Google Ventures, Stanford’s StartX, as well as angel investors.
San Jose, California-based Akibah just launched a crowdfunding campaign for its connected glucometer smartphone case, called GluCase.
NYC-based pharma company Pfizer currently has 15 apps in the US iOS app store, ranging from a chapstick companion app to an app for people with kidney cancer.
Exco InTouch's mobile clinical trial software.
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way.
At the mHealth Summit next week, MobiHealthNews is hosting a breakfast panel discussion: Digital Health's Disruption of Pharma.